Kidney disease in Puumala hantavirus infection

References

• Mustonen J, Mäkelä S, Outinen T, et al. The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions. Antiviral Res. 2013;100:589–604.
   PubMed Web of Science ®Google Scholar
• Vaheri A, Strandin T, Hepojoki J, et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol. 2013;11:539–550.
   PubMed Web of Science ®Google Scholar
• Vaheri A, Henttonen H, Voutilainen L, et al. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.
   PubMed Web of Science ®Google Scholar
• Vaheri A, Vapalahti O, Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol. 2008;18:277–288.
   PubMed Web of Science ®Google Scholar
• Vapalahti O, Lundkvist Å, Kallio-Kokko H, et al. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol. 1996;34:119–125.
   PubMed Web of Science ®Google Scholar
• Elgh F, Lundkvist Å, Alexeyev OA, et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol. 1997;35:1122–1130.
   PubMed Web of Science ®Google Scholar
• Sjölander KB, Elgh F, Kallio-Kokko H, et al. Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica). J Clin Microbiol. 1997;35:3264–3268.
   PubMed Web of Science ®Google Scholar
• Hujakka H, Koistinen V, Kuronen I, et al. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods. 2003;108:117–122.
   PubMed Web of Science ®Google Scholar
• Kanerva M, Mustonen J, Vaheri A. Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol. 1998;8:67–86.
   PubMed Web of Science ®Google Scholar
• Lähdevirta J. Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res. 1971;3:1–54.
   PubMedGoogle Scholar
• Hjertqvist M, Klein SL, Ahlm C, et al. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis. 2010;16:1584–1586.
   PubMed Web of Science ®Google Scholar
• Settergren B, Juto P, Trollfors B, et al. Hemorrhagic complications and other clinical findings in nephropathia epidemica in Sweden: a study of 355 serologically verified cases. J Infect Dis. 1988;157:380–382.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Brummer-Korvenkontio M, Hedman K, et al. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994;26:7–13.
   PubMed Web of Science ®Google Scholar
• Braun N, Haap M, Overkamp D, et al. Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases. Nephrol Dial Transplant. 2010;25:2997–3003.
   PubMed Web of Science ®Google Scholar
• Settergren B, Juto P, Trollfors B, et al. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis. 1989;11:921–927.
   PubMedGoogle Scholar
• Connolly-Andersen AM, Sundberg E, Ahlm C, et al. Increased thrombopoiesis and platelet activation in hantavirus-infected patients. J Infect Dis. 2015;212:1061–1069.
   PubMed Web of Science ®Google Scholar
• Laine O, Joutsi-Korhonen L, Lassila R, et al. Hantavirus infection-induced thrombocytopenia triggers increased production but associates with impaired aggregation of platelets except for collagen. Thromb Res. 2015;136:1126–1132.
   PubMed Web of Science ®Google Scholar
• Settergren B. Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis. 1991;13:736–744.
   PubMedGoogle Scholar
• Outinen TK, Laine OK, Mäkelä S, et al. Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients. Infect Dis (Lond). 2016;48:682–687.
   PubMed Web of Science ®Google Scholar
• Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol. 2001;256:91–115.
   PubMed Web of Science ®Google Scholar
• Hepojoki J, Vaheri A, Strandin T. The fundamental role of endothelial cells in hantavirus pathogenesis. Front Microbiol. 2014;5:727.
   PubMed Web of Science ®Google Scholar
• Strandin T, Hepojoki J, Laine O, et al. Interferons induce STAT1-dependent expression of tissue plasminogen activator, a pathogenicity factor in Puumala Hantavirus disease. J Infect Dis. 2016;213:1632–1641.
   PubMed Web of Science ®Google Scholar
• Laine O, Mäkelä S, Mustonen J, et al. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res. 2010;126:154–158.
   PubMed Web of Science ®Google Scholar
• Paakkala A, Mustonen J, Viander M, et al. Complement activation in nephropathia epidemica caused by Puumala hantavirus. Clin Nephrol. 2000;53:424–431.
   PubMed Web of Science ®Google Scholar
• Sane J, Laine O, Mäkelä S, et al. Complement activation in Puumala hantavirus infection correlates with disease severity. Ann Med. 2012;44:468–475.
   PubMed Web of Science ®Google Scholar
• Ala-Houhala I, Koskinen M, Ahola T, et al. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. Nephrol Dial Transplant. 2002;17:246–252.
   PubMed Web of Science ®Google Scholar
• Settergren B, Trollfors B, Fasth A, et al. Glomerular filtration rate and tubular involvement during acute disease and convalescence in patients with nephropathia epidemica. J Infect Dis. 1990;161:716–720.
   PubMed Web of Science ®Google Scholar
• Goicoechea M, Rivera F, Lopez-Gomez JM, et al. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2013;28:112–115.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Helin H, Pietilä K, et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol. 1994;41:121–126.
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Mustonen J, Ala-Houhala I, et al. Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 2004;43:809–816.
   PubMed Web of Science ®Google Scholar
• Huttunen NP, Mäkelä S, Pokka T, et al. Systematic literature review of symptoms, signs and severity of serologically confirmed nephropathia epidemica in paediatric and adult patients. Scand J Infect Dis. 2011;43:405–410.
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Kokkonen L, Ala-Houhala I, et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis. 2009;41:57–62.
   PubMed Web of Science ®Google Scholar
• Koivula TT, Tuulasvaara A, Hetemäki I, et al. Regulatory T cell response correlates with the severity of human hantavirus infection. J Infect. 2014;68:387–394.
   PubMed Web of Science ®Google Scholar
• Van Loock F, Thomas I, Clement J, et al. A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk?. Clin Infect Dis. 1999;28:834–839.
   PubMed Web of Science ®Google Scholar
• Tervo L, Mäkelä S, Syrjänen J, et al. Smoking is associated with aggravated kidney injury in Puumala hantavirus-induced haemorrhagic fever with renal syndrome. Nephrol Dial Transplant. 2015;30:1693–1698.
   PubMed Web of Science ®Google Scholar
• Vapalahti K, Virtala AM, Vaheri A, et al. Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect. 2010;138:576–584.
   PubMed Web of Science ®Google Scholar
• Bergstedt Oscarsson K, Brorstad A, Baudin M, et al. Human Puumala hantavirus infection in northern Sweden; increased seroprevalence and association to risk and health factors. BMC Infect Dis. 2016;16:566.
   PubMed Web of Science ®Google Scholar
• Kitterer D, Segerer S, Dippon J, et al. Smoking is a risk factor for severe acute kidney injury in Hantavirus-induced nephropathia epidemica. Nephron. 2016;134:89–94.
   PubMed Web of Science ®Google Scholar
• Saha H, Mustonen J, Pietilä K, et al. Metabolism of calcium and vitamin D3 in patients with acute tubulointerstitial nephritis: a study of 41 patients with nephropathia epidemica. Nephron. 1993;63:159–163.
   PubMed Web of Science ®Google Scholar
• Fevola C, Forbes KM, Mäkelä S, et al. Lymphocytic choriomeningitis, Ljungan and orthopoxvirus seroconversions in patients hospitalized due to acute Puumala hantavirus infection. J Clin Virol. 2016;84:48–52.
   PubMed Web of Science ®Google Scholar
• Latus J, Schwab M, Tacconelli E, et al. Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant. 2015;30:245–251.
   PubMed Web of Science ®Google Scholar
• Bunz H, Weyrich P, Peter A, et al. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection. BMC Infect Dis. 2015;15:464.
   PubMed Web of Science ®Google Scholar
• Wagner R, Leicht-Biener U, Mucsi I, et al. Ibuprofen or diclofenac is associated with more severe acute kidney injury in nephropathia epidemica. Scand J Urol Nephrol. 2012;46:65–69.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
   Google Scholar
• Outinen TK, Mäkelä S, Clement J, et al. Community acquired severe acute kidney injury caused by Hantavirus-induced hemorrhagic fever with renal syndrome has a favorable outcome. Nephron. 2015;130:182–190.
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Ala-Houhala I, Mustonen J, et al. Renal function and blood pressure five years after puumala virus-induced nephropathy. Kidney Int. 2000;58:1711–1718.
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. Tubular proteinuria and glomerular filtration 6 years after Puumala hantavirus-induced acute interstitial nephritis. Nephron Clin Pract. 2009;112:c115–c120.
   PubMedGoogle Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 2006;69:2043–2048.
   PubMed Web of Science ®Google Scholar
• Latus J, Schwab M, Tacconelli E, et al. Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany. Emerg Infect Dis. 2015;21:76–83.
   PubMed Web of Science ®Google Scholar
• Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. The severity of acute Puumala hantavirus infection does not predict the long-term outcome of patients. Nephron Clin Pract. 2010;116:c89–c94.
   PubMedGoogle Scholar
• Krautkrämer E, Grouls S, Stein N, et al. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol. 2011;85:9811–9823.
   PubMed Web of Science ®Google Scholar
• Krautkrämer E, Zeier M, Plyusnin A. Hantavirus infection: an emerging infectious disease causing acute renal failure. Kidney Int. 2013;83:23–27.
   PubMed Web of Science ®Google Scholar
• Groen J, Bruijn JA, Gerding MN, et al. Hantavirus antigen detection in kidney biopsies from patients with nephropathia epidemica. Clin Nephrol. 1996;46:379–383.
   PubMed Web of Science ®Google Scholar
• Temonen M, Mustonen J, Helin H, et al. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996;78:47–55.
   PubMedGoogle Scholar
• Mustonen J, Pasternack A, Helin H, et al. Renal biopsy in acute renal failure. Am J Nephrol. 1984;4:27–31.
   PubMed Web of Science ®Google Scholar
• Collan Y, Mihatsch MJ, Lähdevirta J, et al. Nephropathia epidemica: mild variant of hemorrhagic fever with renal syndrome. Kidney Int Suppl. 1991;35:S62–S71.
   PubMedGoogle Scholar
• Kuhlbaeck B, Fortelius P, Tallgren LG. Renal histopathology in a case of nephropathia epidemica myhrman. a study of successive biopsies. Acta Pathol Microbiol Scand. 1964;60:323–333.
   PubMedGoogle Scholar
• Gnemmi V, Verine J, Vrigneaud L, et al. Microvascular inflammation and acute tubular necrosis are major histologic features of hantavirus nephropathy. Hum Pathol. 2015;46:827–835.
   PubMed Web of Science ®Google Scholar
• Jokinen EJ, Lähdevirta J, Collan Y. Nephropathia epidemica: immunohistochemical study of pathogenesis. Clin Nephrol. 1978;9:1–5.
   PubMed Web of Science ®Google Scholar
• Collan Y, Lähdevirta J, Jokinen EJ. Electron microscopy of nephropathia epidemica. glomerular changes. Virchows Arch a Pathol Anat Histol. 1978;377:129–144.
   PubMed Web of Science ®Google Scholar
• Boehlke C, Hartleben B, Huber TB, et al. Hantavirus infection with severe proteinuria and podocyte foot-process effacement. Am J Kidney Dis. 2014;64:452–456.
   PubMed Web of Science ®Google Scholar
• Collan Y, Lähdevirta J, Jokinen EJ. Electron microscopy of nephropathia epidemica. Renal tubular basement membrane. Am J Pathol. 1978;92:167–172.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Mäkelä S, Helin H, et al. Mesangiocapillary glomerulonephritis caused by Puumala hantavirus infection. Nephron. 2001;89:402–407.
   PubMed Web of Science ®Google Scholar
• Miettinen M, Mäkelä S, Haapala M, et al. Glomerulonephritis emerging shortly after Puumala hantavirus infection: a report on 7 patients. Clin Nephrol. 2011;75:550–556.
   PubMed Web of Science ®Google Scholar
• Linderholm M, Sandström T, Rinnström O, et al. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis. 1997;25:1084–1089.
   PubMed Web of Science ®Google Scholar
• Paakkala A, Lempinen L, Paakkala T, et al. Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med. 2004;15:284–290.
   PubMedGoogle Scholar
• Kanerva M, Paakkala A, Mustonen J, et al. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 1996;46:369–378.
   PubMed Web of Science ®Google Scholar
• Clement J. Acute kidney injury and hantavirus disease. In: Turner N, Lameire N, editors. Textbook of clinical nephrology. Oxford (UK): Oxford University Press. 2015. p. 2059–2066.
   Google Scholar
• Paakkala A, Kallio T, Huhtala H, et al. Renal ultrasound findings and their clinical associations in nephropathia epidemica. Analysis of quantitative parameters. Acta Radiol. 2002;43:320–325.
   PubMed Web of Science ®Google Scholar
• Paakkala A, Mustonen J. Radiological findings and their clinical correlations in nephropathia epidemica. Acta Radiol. 2007;48:345–350.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M, et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996;49:217–221.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Huttunen NP, Partanen J, et al. Human leukocyte antigens B8-DRB1*03 in pediatric patients with nephropathia epidemica caused by Puumala hantavirus. Pediatr Infect Dis J. 2004;23:959–961.
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Mustonen J, Ala-Houhala I, et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis. 2002;186:843–846.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998;47:277–279.
   PubMed Web of Science ®Google Scholar
• McNeil AJ, Yap PL, Gore SM, et al. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM. 1996;89:177–185.
   PubMed Web of Science ®Google Scholar
• Steel CM, Ludlam CA, Beatson D, et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet. 1988;1:1185–1188.
   PubMed Web of Science ®Google Scholar
• Laine O, Joutsi-Korhonen L, Mäkelä S, et al. Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection. Thromb Res. 2012;129:611–615.
   PubMed Web of Science ®Google Scholar
• Koskela S, Laine O, Mäkelä S, et al. Endothelial nitric oxide synthase g894t polymorphism associates with disease severity in Puumala Hantavirus infection. PLoS One. 2015;10:e0142872.
   Web of Science ®Google Scholar
• Charbonnel N, Pages M, Sironen T, et al. Immunogenetic factors affecting susceptibility of humans and rodents to hantaviruses and the clinical course of hantaviral disease in humans. Viruses. 2014;6:2214–2241.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä SM, Ala-Houhala IO, et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis. 2010;10:132.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä S, Huhtala H, et al. High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur J Clin Microbiol Infect Dis. 2012;31:957–963.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä SM, Ala-Houhala IO, et al. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica. J Med Virol. 2011;83:731–737.
   PubMed Web of Science ®Google Scholar
• Huttunen R, Kuparinen T, Jylhävä J, et al. Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: a prospective cohort study. PLoS One. 2011;6:e21700.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Kuparinen T, Jylhävä J, et al. Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection. PLoS One. 2012;7:e31455
   PubMed Web of Science ®Google Scholar
• Outinen TK, Tervo L, Mäkelä S, et al. Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS One. 2013;8:e71335.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä S, Huttunen R, et al. Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infection. J Intern Med. 2014;276:387–395.
   PubMed Web of Science ®Google Scholar
• Libraty DH, Mäkelä S, Vlk J, et al. The Degree of Leukocytosis and Urine GATA-3 mRNA Levels Are Risk Factors for Severe Acute Kidney Injury in Puumala Virus Nephropathia Epidemica. PLoS One. 2012;7:e35402.
   PubMed Web of Science ®Google Scholar
• Hepojoki J, Strandin T, Hetzel U, et al. Acute hantavirus infection induces galectin-3-binding protein. J Gen Virol. 2014;95:2356–2364.
   PubMed Web of Science ®Google Scholar
• Rusnak JM, Byrne WR, Chung KN, et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res. 2009;81:68–76.
   PubMed Web of Science ®Google Scholar
• Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164:1119–1127.
   PubMed Web of Science ®Google Scholar
• Antonen J, Leppänen I, Tenhunen J, et al. A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand J Infect Dis. 2013;45:494–496.
   PubMed Web of Science ®Google Scholar
• Vaheri A, Strandin T, Jääskeläinen AJ, et al. Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Antiviral Res. 2014;111:23–25.
   PubMed Web of Science ®Google Scholar
• Laine O, Leppänen I, Koskela S, et al. Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant. Infect Dis (Lond). 2015;47:107–111.
   PubMed Web of Science ®Google Scholar
• Taylor SL, Wahl-Jensen V, Copeland AM, et al. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog. 2013;9:e1003470.
   PubMed Web of Science ®Google Scholar
• Koskela SM, Laine OK, Paakkala AS, et al. Spleen enlargement is a common finding in acute Puumala hantavirus infection and it does not associate with thrombocytopenia. Scand J Infect Dis. 2014;46:723–726.
   PubMed Web of Science ®Google Scholar